Biotec Pharmacon ASA [clinicaltrials_resource:eb8838ceead784fd6e8ec72ed9d6b157]
Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns [clinicaltrials:NCT00283426]Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients [clinicaltrials:NCT00288392]The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients [clinicaltrials:NCT00289003]Effect of SBG in Patients With Breast Cancer [clinicaltrials:NCT00533364]Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00533728]Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers [clinicaltrials:NCT00632008]Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy [clinicaltrials:NCT00790322]Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers [clinicaltrials:NCT00804414]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns [clinicaltrials:NCT00283426]Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients [clinicaltrials:NCT00288392]The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients [clinicaltrials:NCT00289003]Effect of SBG in Patients With Breast Cancer [clinicaltrials:NCT00533364]Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00533728]Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers [clinicaltrials:NCT00632008]Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy [clinicaltrials:NCT00790322]Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers [clinicaltrials:NCT00804414]
source [clinicaltrials_vocabulary:source]
Biotec Pharmacon ASA [clinicaltrials_resource:eb8838ceead784fd6e8ec72ed9d6b157]
Bio2RDF identifier
eb8838ceead784fd6e8ec72ed9d6b157
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:eb8838ceead784fd6e8ec72ed9d6b157
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:eb8838ceead784fd6e8ec72ed9d6b157
title
Biotec Pharmacon ASA
@en
type
label
Biotec Pharmacon ASA [clinicaltrials_resource:eb8838ceead784fd6e8ec72ed9d6b157]
@en